AI-Enhanced Care Nerbio’s iTOF platform combines FDA-cleared wireless hardware with AI assistance to improve neuromuscular monitoring and postoperative recovery timing, presenting a compelling upsell to hospitals seeking safer, more efficient perioperative workflows and reduced capital spend on bulky equipment.

Mobile Clinical Tech The app-controlled, smartphone and tablet-enabled monitoring reduces dependency on large, standalone devices, creating a strong value proposition for health systems looking to modernize operating rooms and enable bedside, point-of-care assessments at lower total cost of ownership.

Mid-Sized Market Fit With 11-50 employees and a revenue range of 10–25 million, Nerbio sits in a scalable niche that can rapidly expand through clinical partnerships, pilot programs, and reference sites within mid-size hospitals and regional health networks.

Cloud-Native Platform Leveraging AWS, Cloudflare, and cloud-based data capabilities, Nerbio can offer secure, scalable integration with hospital IT and EHR environments, enabling new integration partnerships, data-driven outcomes analytics, and expanded device fleets.

Growth via AI-Driven Outcomes The AI-assisted TOF monitoring enables precise dosing guidance and timing for recovery, creating opportunities to partner with anesthesiology groups, perioperative services, and patient safety initiatives focused on reducing complications, length of stay, and readmission risks.